Environmental Influences on Stem Cell BehaviourView this Special Issue
Review Article | Open Access
Tissue Regeneration without Stem Cell Transplantation: Self-Healing Potential from Ancestral Chemistry and Physical Energies
The human body constantly regenerates after damage due to the self-renewing and differentiating properties of its resident stem cells. To recover the damaged tissues and regenerate functional organs, scientific research in the field of regenerative medicine is firmly trying to understand the molecular mechanisms through which the regenerative potential of stem cells may be unfolded into a clinical application. The finding that some organisms are capable of regenerative processes and the study of conserved evolutionary patterns in tissue regeneration may lead to the identification of natural molecules of ancestral species capable to extend their regenerative potential to human tissues. Such a possibility has also been strongly suggested as a result of the use of physical energies, such as electromagnetic fields and mechanical vibrations in human adult stem cells. Results from scientific studies on stem cell modulation confirm the possibility to afford a chemical manipulation of stem cell fate in vitro and pave the way to the use of natural molecules, as well as electromagnetic fields and mechanical vibrations to target human stem cells in their niche inside the body, enhancing human natural ability for self-healing.
The human body continuously regenerates due to the peculiar properties of its resident stem cells.
These cells possess the unique ability to self-renew and differentiate, and the balance between these two processes defines the stem cell fate and their primary role in tissue regeneration .
Regeneration is the recovery of the organ structure and function after injury and it is at the basis of our self-healing potential and therefore of the preservation of human health. Such a process exhibits remarkable grading in the way it is fashioned in living organisms, since, within the same species, the regenerative potential is different among the various organs .
To rescue damaged tissues and restore functional organ mass, huge efforts have been made in the growing field of regenerative medicine, engaging scientific research in the understanding of the molecular mechanisms through which the regenerative potential of stem cells (as human mesenchymal stem cells - hMSCs) may be unfolded into a clinical application . Stem cells in fact have the capability to differentiate into a wide range of adult cells and the discovery and isolation of them paved the way to new hopes in the regenerative field.
On the other hand, many aspects of the cell-based therapy prevent the use of stem cells to regenerate organs and tissues: among them, a large amount of stem cells is required and the senescence process occurs during primary cell expansion. Moreover, it is not easy to isolate stem cells and to commit all of them toward a specific phenotype, since they can differentiate in all types of mature cells, including cancer cells. Therefore, a proper set up of in vitro MSC expansion, cryopreservation, and banking should be necessary to establish safety and efficacy in transplanted patients.
In addition, most of the applications of stem cells directed on patients are still under the phase of experimental trials, except for some procedures actually used in clinical practice, as the bone marrow transplantation in hematology .
Even tissue engineering, one of the branches of the regenerative medicine based upon tissue regeneration from cells with the aid of biomaterials and growth factors, still is facing several problems. In fact, the regenerated tissues usable by patients are still very limited, as skin, bone, cartilage, capillary, and periodontal tissues . Moreover, the engineered artificial tissue still exhibits some limitation correlated to the dimensions of the construct that cannot be used for the recovery of serious defects. Actually, the only amenable engineered tissues with a tridimensional structure are vases, cave structures like the trachea , or tissues which are not physiologically scattered, since the viability of cells seeded on a scaffold gradually decreases with thickness. Even the use of growth factors alone or in association with 3D constructs is still considered as being not completely safe since the resulting influence on recipient’s environment remains in part to be established. Finally, other hurdles remain, such as finding the best scaffold, the most suitable bioreactor, and the optimal solution for seeding different cell populations in order to have a relevant mature material implantable on patients.
All these issues need to be addressed before cells or engineered constructs can be used routinely in the clinical setting. Therefore, multiple studies have long been running to address the modulation of relevant physiological traits known to be involved in tissue homeostasis and in the activation of the stem cell niches. To this end, besides investigating the effects of synthetic molecules, many researchers have also focused their attention on the effects elicited by natural molecules and physical energies. Their findings are reported below.
2. Natural Molecules
The ability to regrow body parts is common to a lot of animal species, although the regenerative potential varies among taxa . Some phyla are able to rebuild every part of the body, while others cannot regenerate internal organs .
Danio rerio (zebrafish) is among the organisms capable of amazing regenerative processes, prompting the needs for uncovering the underlying regeneration strategies. Zebrafish is since recently commonly used as an animal model of organogenesis and regeneration, owing to its ability to regenerate complex organs, like the heart, the central nervous system, and the limbs, at an extraordinarily higher efficacy than humans [2, 3, 9–16]. Another species exhibiting astonishing regenerative potential is the Mexican axolotl (Ambystoma mexicanum), which can make self-copies regenerating a missing limb, tail, or parts of the brain, heart, and lower jaw. Other creatures in the spotlight for their regenerative capabilities are the salamanders, as well as several frogs , or the tunicates . Despite their evolutionary distance, as in the case of zebrafish which is separated by about 450 million years from humans, our stem cells can still sense ancestral microenvironmental cues from these species, as shown by the finding that human cord blood CD34+ cells are recruited into early vasculogenesis upon transplantation in pre-gastrulation, but not post-gastrulation zebrafish embryos . Akin to this view is the finding that conserved transcriptional responses have been discovered among the differentiation of hMSCs, Xenopus embryogenesis, and axolotl regeneration, identifying common networks across model species that are associated with depolarization (changes in cellular resting potential) .
On the whole, these findings and the deployment of comparative biology into the analysis of conserved evolutionary patterns in tissue regeneration may lead to the identification of natural molecules capable to extend their regenerative potential from ancestral species to human tissues through the manipulation of common/similar mechanisms in their resident stem cells.
Investigation of the role of natural molecules in stem cell biology is becoming a growing area of inquiry. Psoralidin, for example, a natural phenolic compound found in the seeds of Psoralea corylifolia, has been seen to inhibit NOTCH1 in breast cancer stem cells and in breast cancer cells, leading to a growth arrest and inhibition of epithelial to mesenchymal transition (EMT) . Moreover, two herbal extracts (Tithonia diversifolia leaf extract and Momordica foetida extract) led to a decrease of the adipogenesis and accumulation of lipid droplets in human adipose-derived stem cells (hADSCs) [22, 23]. Two natural compounds, honokiol (a low-molecular-weight polyphenol isolated from the genus Magnolia) and hyperoside (a flavonoid compound extracted from Hypericum perforatum), were shown to potentially induce the differentiation into neurons in the murine embryonic carcinoma cell line P19 . Synthetic compounds created by the assembly of natural molecules have also been proven effective in the modulation of stem cell biology in vitro and in vivo. To this end, mixed esters of naturally occurring molecules, such as hyaluronan mixed esters with butyric and retinoic acids (HBR), have been shown to remarkably increase cardiogenesis and vasculogenesis in mouse embryonic stem cells  and hMSCs , enhancing the ability of term placenta hMSCs of promoting the regeneration of infarcted myocardium in vivo in both small (rat) and large (pig) animal models with post infarct heart failure [27, 28]. Intriguingly, in the myocardium of infarcted rats, HBR itself acted through the intracellular release of its natural grafted molecules to afford significant decrease in infarct size, and apoptotic myocytes, leading to reverse myocardial remodeling, normalization in myocardial contractility, and increase in vital myocardial mass and metabolism, through the enhancement/recruitment of the number of endogenous stro-1 (a mesenchymal stem cell marker)-positive stem cells, the increase in the number of local elements with pericyte identity and important revascularization processes . This finding shows the feasibility of chemical targeting damaged organs to afford tissue survival and repair without stem cell transplantation. Consonant with these results, a simple cocktail of hyaluronic, butyric, and retinoic acids was able to improve islet graft revascularization and function by adipose tissue-derived hMSCs in diabetic rats .
The addition of melatonin to this mixture of natural molecules was able to shift the commitment of hMSCs towards an osteogenic fate, indicating the feasibility of creating a multicomponent, multitarget ensemble of natural agents to chemically redirect the multilineage repertoire of hMSCs .
A major breakthrough in the effort of using natural arrays of molecules to drive cellular fates under normal and pathological conditions came by the discovery that extracts from zebrafish embryos obtained at different developmental stages were able to counteract the proliferation rate of several cancer cell lines [32–35]. Extracts from the beginning, intermediate and final embryonic development stages led to an evident increase in p53 expression in association with the growth reduction . In some cancer cell lines, such as kidney adenocarcinoma, the proliferation decrease was associated with changes in pRb phosphorylation, a cell cycle modulator . Moreover, in colon adenocarcinoma cells, an activation of the p73-dependent apoptotic pathway was observed . A mixture of early, middle, and late developmental stage zebrafish extracts was also able to enhance cell survival to toxic stimuli, as shown by the reduction in mortality observed in cells from mouse hippocampal slices (CA1 area) that had been subjected to serum deprivation or NMDA (N-methyl-D-aspartate) treatment . These findings and previous observations showing that embryonic microenvironment is able to suppress tumor development during cell differentiating processes [37, 38] led us to further investigate whether zebrafish embryonic factors may also be exploited in a developmental stage manner to control essential features in stem cell dynamics. To this end, we successfully used early-stage developmental zebrafish extracts (obtained from 5.15 hours post fertilization embryos) on early-passage hADSCs to enhance the stem cell expression of multipotency, and the transcription of TERT, encoding the catalytic subunit of telomerase, as well as the gene expression of BMI1, a chromatin remodeler acting as a major telomerase-independent repressor of senescence .
On the whole, the above mentioned studies, showing the possibility to afford a chemical manipulation of stem cell fate in vitro, may pave the way to the use of natural or synthetic chemistry to target human stem cells where they are already resident in all body tissues. This would lead to the development of a regenerative medicine executed without the needs for (stem) cell or tissue transplantation.
3. Physical Energies
The possibility of using physical energies to boost regenerative processes has been strongly suggested by the ability of electromagnetic fields and mechanical vibrations to drive efficient in situ reprogramming of the differentiating and regenerative potential of our endogenous stem cells.
We are in fact embedded in a wide variety of physical stimuli, including electromagnetic fields, light radiation, and mechanical oscillatory patterns. In this sense, our life which contains a seeming infinity of rhythmic oscillations, including calcium and pH intracellular oscillations [40–42], as well as the rhythmic expression of genes and proteins [43, 44], can be considered as a part of the vibratory nature of the universe.
It is now evident that our cells perceive and generate energies like magnetic fields and mechanical oscillations [45–47]. Cells contain a network of microtubules that, due to their electrical polarity and intrinsic vibration modes, is able to generate high-frequency electric fields with radiation features . Applying scanning tunneling microscopy (STM) to microtubules growing onto a nanoelectrode array, within an artificial cell replica designed to pump electromagnetic frequencies, has shown the existence of resonance patterns between the tubulin dimers, or the whole microtubules, and the applied frequencies . STM also provided evidence that such resonance patterns could be imaged as specific “tunneling current profiles” corresponding to the pumped electromagnetic frequencies . The frequency region selectivity for engaging particular types of conformational modifications establishes that pure mechanical changes can be remotely managed in an atomically way by using electromagnetic fields.
The importance of the microtubule network as an information-transporting-system is also deduced by the finding of multilevel memory-switching properties in a single brain microtubule . Even DNA, despite its role of storage and expression of genetic information, when considered as an electrically charged vibrational entity, may contribute to cell polarity, also by virtue of its constant assembly into different loops and domains that are an essential component of the nanomechanics and nanotopography imparted to this macromolecule by transcription factors and molecular motors. Accordingly, electromagnetic resonance frequency spectra have been revealed for DNA, which was found to exhibit electromagnetic resonances in the wide frequency range from KHz, MHz, GHz, to THz .
Recently, regenerative medicine has been focused on the use of biophysical stimuli to modulate cellular dynamics . Physical factors in the cellular microenvironment, including matrix mechanics, cell geometry and shape, mechanical forces, and nanotopographical aspects of the extracellular matrix, can modulate the stem cell fate [53, 54]. There is evidence that this type of regulation is highly affected by coexisting insoluble, adhesive, mechanical, and topological cues contained and dynamically regulated within the stem cell niche [55, 56]. Biophysical stimuli can be sensed and transduced into intracellular biochemical and functional responses by stem cells, a process known as mechano-transduction . The stem cell sensory machinery can at the same time perceive and integrate several signals from the niche and turn them into coherent responses affording downstream modulation of gene expression and stem cell fate [55, 57–59].
For years, scientists tried to drive stem cell fate by the aid of chemistry, increasing cell proliferation with growth factors or fabricating 3D constructs derived from the combination of stem cells or mature adult cells, with natural or artificial polymers. Only in the last years, efforts have been made to interact with cells in vivo, directly on patients or on animal models, and in vitro on cell cultures. Recently, some research groups have shown the possibility to use physical stimuli directly on patients, tissues, and cells .
The idea behind the use of physical stimuli on tissues and body was already proposed in 1974 by Richard Nuccitelli who gained evidence on endogenous ionic current and interaction with electric field in multicellular animal tissues . Nowadays, it is possible to explain changes in cellular behavior, following electromagnetic stimulation, considering an effect on cell polarity  and on the stem cell niche in the body .
The use of physical energies for therapeutic purpose is now well known, being approved by the Food and Drug Administration (FDA) and used on patients. Several devices based on different physical mechanisms have been designed, and the beneficial effects have been observed directly on patients. Ultrasounds have been used for medical purposes since the 1950 in some pathological situations, such as tendinitis or bursitis .
Even the use of extremely low-frequency electromagnetic fields (ELF-EMFs) with frequencies lower than 100 Hz, and magnetic field intensity spanning from 0.1 to 20 mT, became a useful therapy for soft tissue regeneration, fracture repair, and osteoporosis treatment . The mechanisms of action of ELF-EMFs are not clear yet. However, it has been shown that electric currents can accelerate cell activation  and influence epigenetic remodeling. In particular, the use of 50 Hz ELF-EMF on GC-2 cells decreased genome-wide methylation and the expression of DNA methyltransferases  in neural stem cells (NSCs) isolated from the hippocampus of newborn mice. Moreover, the ELF-EMF irradiation at 1 mT, and 50 Hz, for 12 days enhanced NSC proliferation and neuronal cell fate specification through Cav1 channel-dependent regulation and histone modification . These results show the feasibility of using physical stimuli to affect cell fate.
Within this context, we have first demonstrated the possibility to use ELF-EMFs to modulate the gene transcription of essential growth regulatory peptides in adult myocardial cells  and to enhance cardiogenesis and terminal differentiation into spontaneously beating myocardial cells in mouse embryonic stem (ES) cells . Then, by the aid of a radio electric asymmetric conveyer (REAC), we found that properly conveyed radioelectric fields of 2.4 GHz could produce important biological effects in mouse ES cells and human adult stem cells. In both cell types, we showed that REAC-conveyed radioelectric fields elicited an increase of the expression of stemness-related genes, followed by the commitment towards neuronal, myocardial, and skeletal muscle lineages [70, 71]. The same differentiating outcomes were induced by REAC exposure in human skin fibroblasts : for the first time, human non-stem somatic adult cells were committed to lineages in which they would never otherwise appear. This effect was mediated by a biphasic change in pluripotency gene expression, a temporary overexpression followed by a down regulation, and did not require the use of viral vector-mediated gene transfer technologies or cumbersome synthetic chemistry.
Noteworthy, REAC exposure of hADSCs was able to turn stem cell senescence, occurring after prolonged (up to 30 passage) in vitro expansion, into a reversible phenomenon, associated with a decrease in the expression of senescence-associated β-galactosidase and an increase in TERT gene expression and telomere length. The REAC action also enhanced the gene transcription of BMI1 and that of stemness-related genes, establishing a telomerase-independent arm for senescence reversal . These findings may have important biomedical implications, since senescent stem cells decrease their self-renewal and differentiation potential, reducing their ability for tissue regeneration in vivo and the possibility of a prolonged expansion in vitro prior to transplantation.
Compounding the wide-ranging biological effects of REAC stimulation is the observation that this technology was able to promote neurological and morphofunctional differentiation in PC12 cells , a rat adrenal pheochromocytoma cell line displaying metabolic features of Parkinson’s disease. Cell response to the electromagnetic field was mediated by the transcriptional activation of neurogenic genes, as neurogenin-1, β3-tubulin, and nerve growth factor (NGF), and was associated with a consistent increase in the number of cells expressing both β3-tubulin and tyrosine hydroxylase . These findings open the new perspective of using physical energies in the treatment of neurodegenerative diseases and in the reprogramming of cancer (stem) cells into normal regenerative elements. More recently, we found that the REAC action could be significantly counteracted by stem cell treatment with 4-methylumbelliferone (4-MU), a potent repressor of type-2 hyaluronan (HA) synthase and endogenous HA synthesis . This observation suggests that REAC-mediated responses may have occurred through an essential pleiotropic role of this glycosaminoglycan in regulating (stem) cell polarity.
Extracorporeal shock waves (ESW) represent another type of biophysical stimuli that is increasingly being applied in the field of regenerative medicine and that could be classified as “mechanotherapy” (i.e., extracorporeal shock wave therapy, ESWT). In fact, ESW are “mechanical” waves, characterized by an initial positive very rapid phase, of high amplitude, followed by negative pressure, producing a “microexplosion” that can be directed on a target zone (body, tissue, or cells) in order to stimulate or modify the cells in their behavior. Shock waves are generated by an electrohydraulic device that produces underwater high-voltage condenser spark discharge, conveyed by an elliptical reflector on tissues or cells.
In the 1980s, shock waves were used in urology (lithotripsy) to disintegrate renal stones . Then, ESW application has been extended to other fields, showing promising hopes for promoting tissue healing and the recovery from pathological disorders. One of the first applications was in the orthopedic field, in order to induce neovascularization and improve blood supply and tissue regeneration. Investigations on the use of this technology spread progressively, and leading to its application in the treatment of musculoskeletal disorders , tendon pathologies , bone healing disturbances, and vascular bone diseases . The use of ESW has also been extended to the field of dermatology for the wound healing disturbances and ulcers. However, to date, the exact mechanism through which cells convert mechanical signals into biochemical responses is not well understood yet. Emphasis has been placed so far into mechanisms mediated by ATP release and P2 receptor activation that may foster cell proliferation and tissue remodeling via Erk1/2 activation [80, 81], as well as PI-3K/AKT and NF-κB signaling pathways, and the implication of TLR3 signaling and subsequent TLR4. Several studies performed in vitro proved the effect of ESW on cell modulation through “mechano-transduction”. Recently, ESW were found to activate ADSCs through MAPK, PI-3K/AKT, and NF-κB signaling pathways [82, 83] and to induce in HUVEC cells an overexpression of angiogenic factors and of caveolin-1, a constitutive protein of caveolae, implicated in the regulation of cell growth, lipid trafficking, endocytosis, and cell migration .
In addition, the ESWT effect on cell behavior proved to be a dose-dependent phenomenon. In a study published by Zhang and coworkers, cells exposed to low-energy ESW (0.04 e 0.13 mJ/mm2) improved the expression of some angiogenic factors, such as eNOS, Ang-1, and Ang-2. On the other hand, at higher energy, ESW induced a reduction in angiogenic factor expression and an increase in apoptosis . These findings suggest that the biological effects of shock waves strongly correlated with the intensity of applied energy and thus with the related mechanical forces.
Recently, the effects of shock waves have been characterized on the expression of IL-6, IL-8, MCP-1, and TNF-α in human periodontal ligament fibroblasts . Following an early inhibition on the expression of pro-inflammatory mediators, shock waves elicited a dose-related increase in IL-6 and IL-8, while down-regulating TNF-α expression . Most of the literature showed an anti-inflammatory effect of ESWT in vivo [59, 78, 79, 87, 88]. Nevertheless, the pro-inflammatory effect of ESWT partially observed on cells in vitro may suggest a pro-activator event mediated by cytokine and chemokine expression. It was supposed that the shock wave impulses on cells were able to create a pro-inflammatory milieu, mediated by mechano-transduction . However, this mechanism may involve a more complex action on the whole niche architecture, with the embedded (stem) cells behaving as sensors and activators of the regenerative response.
In actual fact, mechanical vibration may represent a relevant modality to affect stem cell reprogramming in vivo without having to resort to transplantation procedures. In this regard, we have shown and patented for the first time the cell ability to exhibit “vibrational” (nanomechanical) signatures of their health and their multilineage repertoire . Wide-ranging vital processes are fashioned around the nanomechanical features of subcellular structures, like the microtubular networks, imparting feature characteristic of connectedness and synchronization that can be transferred and recorded from the cell surface. Atomic force microscopy (AFM) can be used to gain insights on cellular nanomechanical properties [89, 90], providing the chance to identify vibrational signatures that can be used to drive lineage-specific commitments in different stem cell populations in vitro or even in vivo to promote endogenous rescue in diseased organs.
The emerging view of a (stem) cell biology governed by physical forces and influenced by ancestral natural molecules may lead us to reinterpret the way we envision the field of regenerative medicine for a near future.
In fact, due to the diffusive nature of electromagnetic fields and mechanical vibrations, the chance is emerging to target and reprogram the stem cells where they are, enhancing our natural ability for self-healing without the needs for (stem) cell transplantation which still shows remarkable limitations.
Conflicts of Interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.
Federica Facchin and Eva Bianconi contributed equally as co-first authors to this study.
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: funded by Eldor Lab, Milan, Italy, and AMeC (Associazione Medicina e Complessità), Via Valdirivo 19, 34100 Trieste, Italy.
- C. Chen, J. M. Fingerhut, and Y. M. Yamashita, “The ins(ide) and outs(ide) of asymmetric stem cell division,” Current Opinion in Cell Biology, vol. 43, pp. 1–6, 2016.
- T. L. Tal, J. A. Franzosa, and R. L. Tanguay, “Molecular signaling networks that choreograph epimorphic fin regeneration in zebrafish – a mini-review,” Gerontology, vol. 56, no. 2, pp. 231–240, 2010.
- W. Shi, Z. Fang, L. Li, and L. Luo, “Using zebrafish as the model organism to understand organ regeneration,” Science China Life Sciences, vol. 58, no. 4, pp. 343–351, 2015.
- T. Reinfjell, M. Tremolada, and L. K. Zeltzer, “A review of demographic, medical, and treatment variables associated with health-related quality of life (HRQOL) in survivors of hematopoietic stem cell (HSCT) and bone marrow transplantation (BMT) during childhood,” Frontiers in Psychology, vol. 8, pp. 8–253, 2017.
- S. Caddeo, M. Boffito, and S. Sartori, “Tissue engineering approaches in the design of healthy and pathological in vitro tissue models,” Frontiers in Bioengineering and Biotechnology, vol. 5, pp. 5–40, 2017.
- J. X. Law, L. L. Liau, B. S. Aminuddin, and B. H. I. Ruszymah, “Tissue-engineered trachea: a review,” International Journal of Pediatric Otorhinolaryngology, vol. 91, pp. 55–63, 2016.
- E. M. Tanaka and P. W. Reddien, “The cellular basis for animal regeneration,” Developmental Cell, vol. 21, no. 1, pp. 172–185, 2011.
- A. E. Bely, “Evolutionary loss of animal regeneration: pattern and process,” Integrative and Comparative Biology, vol. 50, no. 4, pp. 515–527, 2010.
- W. Goessling and T. E. North, “Repairing quite swimmingly: advances in regenerative medicine using zebrafish,” Disease Models & Mechanisms, vol. 7, no. 7, pp. 769–776, 2014.
- S. E. Brockerhoff and J. M. Fadool, “Genetics of photoreceptor degeneration and regeneration in zebrafish,” Cellular and Molecular Life Sciences, vol. 68, no. 4, pp. 651–659, 2011.
- T. Becker and C. G. Becker, “Axonal regeneration in zebrafish,” Current Opinion in Neurobiology, vol. 27, pp. 186–191, 2014.
- K. D. Poss, L. G. Wilson, and M. T. Keating, “Heart regeneration in zebrafish,” Science, vol. 298, no. 5601, pp. 2188–2190, 2002.
- K. D. Poss, M. T. Keating, and A. Nechiporuk, “Tales of regeneration in zebrafish,” Developmental Dynamics, vol. 226, no. 2, pp. 202–210, 2003.
- K. K. McCampbell and R. A. Wingert, “New tides: using zebrafish to study renal regeneration,” Translational Research, vol. 163, no. 2, pp. 109–122, 2014.
- C. Kizil, J. Kaslin, V. Kroehne, and M. Brand, “Adult neurogenesis and brain regeneration in zebrafish,” Developmental Neurobiology, vol. 72, no. 3, pp. 429–461, 2012.
- K. Kikuchi, “Advances in understanding the mechanism of zebrafish heart regeneration,” Stem Cell Research, vol. 13, no. 3, pp. 542–555, 2014.
- J. A. Coffman, S. Rieger, A. N. Rogers, D. L. Updike, and V. P. Yin, “Comparative biology of tissue repair, regeneration and aging,” NPJ Regenerative Medicine, vol. 1, no. 1, article 16003, 2016.
- M. Hamada, S. Goricki, M. S. Byerly, N. Satoh, and W. R. Jeffery, “Evolution of the chordate regeneration blastema: differential gene expression and conserved role of notch signaling during siphon regeneration in the ascidian Ciona,” Developmental Biology, vol. 405, no. 2, pp. 304–315, 2015.
- O. Pozzoli, P. Vella, G. Iaffaldano et al., “Endothelial fate and angiogenic properties of human CD34+ progenitor cells in zebrafish,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 7, pp. 1589–1597, 2011.
- V. P. Pai, C. J. Martyniuk, K. Echeverri, S. Sundelacruz, D. L. Kaplan, and M. Levin, “Genome–wide analysis reveals conserved transcriptional responses downstream of resting potential change in Xenopus embryos, axolotl regeneration, and human mesenchymal cell differentiation,” Regeneration, vol. 3, no. 1, pp. 3–25, 2016.
- S. Suman, T. P. Das, and C. Damodaran, “Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells,” British Journal of Cancer, vol. 109, no. 10, pp. 2587–2596, 2013.
- C. Di Giacomo, L. Vanella, V. Sorrenti et al., “Effects of Tithonia diversifolia (Hemsl.) A. Gray extract on adipocyte differentiation of human mesenchymal stem cells,” PLoS One, vol. 10, no. 4, article e0122320, 2015.
- R. Acquaviva, C. Di Giacomo, L. Vanella et al., “Antioxidant activity of extracts of Momordica Foetida Schumach. et Thonn,” Molecules, vol. 18, no. 3, pp. 3241–3249, 2013.
- T. Chen, J. Wang, M. Liu, L. Y. Zhang, and H. Liao, “Screening of natural compounds with neuronal differentiation promoting effects in a cell–based model,” Chinese Journal of Natural Medicines, vol. 13, no. 8, pp. 602–608, 2015.
- C. Ventura, M. Maioli, Y. Asara et al., “Butyric and retinoic mixed ester of hyaluronan. A novel differentiating glycoconjugate affording a high throughput of cardiogenesis in embryonic stem cells,” The Journal of Biological Chemistry, vol. 279, no. 22, pp. 23574–23579, 2004.
- M. Maioli, S. Santaniello, A. Montella et al., “Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells,” PLoS One, vol. 5, no. 11, article e15151, 2010.
- C. Ventura, S. Cantoni, F. Bianchi et al., “Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts,” The Journal of Biological Chemistry, vol. 282, no. 19, pp. 14243–14252, 2007.
- A. Simioniuc, M. Campan, V. Lionetti et al., “Placental stem cells pre–treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study,” Cardiovascular Research, vol. 90, no. 3, pp. 546–556, 2011.
- V. Lionetti, S. Cantoni, C. Cavallini et al., “Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation,” The Journal of Biological Chemistry, vol. 285, no. 13, pp. 9949–9961, 2010.
- G. Cavallari, E. Olivi, F. Bianchi et al., “Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue–derived stem cells preconditioned with natural molecules,” Cell Transplantation, vol. 21, no. 12, pp. 2771–2781, 2012.
- M. Maioli, V. Basoli, S. Santaniello et al., “Osteogenesis from dental pulp derived stem cells: a novel conditioned medium including melatonin within a mixture of hyaluronic, butyric, and retinoic acids,” Stem Cells International, vol. 2016, Article ID 2056416, 8 pages, 2016.
- P. M. Biava, D. Bonsignorio, and M. Hoxa, “Cell proliferation curves of different human tumor lines after in vitro treatment with zebrafish embryonic extracts,” Journal of Tumor Marker Oncology, vol. 16, pp. 195–202, 2001.
- P. M. Biava and A. Carluccio, “Activation of anti–oncogene p53 produced by embryonic extracts in vitro tumor cells,” Journal of Tumor Marker Oncology, vol. 12, pp. 9–15, 1977.
- P. M. Biava, D. Bonsignorio, M. Hoxa et al., “Post–translational modification of the retinoblastoma protein (pRb) induced by in vitro administration of zebrafish embryonic extracts on human kidney adenocarcinoma cell line,” Journal of Tumor Marker Oncology, vol. 17, pp. 59–64, 2002.
- A. Cucina, P. M. Biava, F. D’Anselmi et al., “Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2),” Apoptosis, vol. 11, no. 9, pp. 1617–1628, 2006.
- P. M. Biava, S. Canaider, F. Facchin et al., “Stem cell differentiation stage factors from zebrafish embryo: a novel strategy to modulate the fate of normal and pathological human (stem) cells,” Current Pharmaceutical Biotechnology, vol. 16, no. 9, pp. 782–792, 2015.
- L. Einhorn, “Are there factors preventing cancer development during embryonic life?” Oncodevelopmental Biology and Medicine, vol. 4, no. 3, pp. 219–229, 1983.
- M. S. Lakshmi and G. V. Sherbet, Embryonic and Tumour Cell Interactions, G. V. Sherbet, Ed., Karger Basel, New York, NY, USA, 1974.
- S. Canaider, M. Maioli, F. Facchin et al., “Human stem cell exposure to developmental stage zebrafish extracts: a novel strategy for tuning stemness and senescence patterning,” CellR4, vol. 2, article e1226, 2014.
- C. Ventura, M. C. Capogrossi, H. A. Spurgeon, and E. G. Lakatta, “Kappa–opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 261, 5 Part 2, pp. H1671–H1674, 1991.
- C. Ventura, H. Spurgeon, E. G. Lakatta, C. Guarnieri, and M. C. Capogrossi, “Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons,” Circulation Research, vol. 70, no. 1, pp. 66–81, 1992.
- M. Nivala, C. Y. Ko, M. Nivala, J. N. Weiss, and Z. Qu, “The emergence of subcellular pacemaker sites for calcium waves and oscillations,” The Journal of Physiology, vol. 591, no. 21, pp. 5305–5320, 2013.
- R. Kageyama, T. Ohtsuka, and T. Kobayashi, “The Hes gene family: repressors and oscillators that orchestrate embryogenesis,” Development, vol. 134, no. 7, pp. 1243–1251, 2007.
- Y. Masamizu, T. Ohtsuka, Y. Takashima et al., “Real–time imaging of the somite segmentation clock: revelation of unstable oscillators in the individual presomitic mesoderm cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1313–1318, 2006.
- G. Albrecht-Buehler, “Rudimentary form of cellular ‘vision’,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 17, pp. 8288–8292, 1992.
- G. Albrecht-Buehler, “A long-range attraction between aggregating 3T3 cells mediated by near-infrared light scattering,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5050–5055, 2005.
- G. Uzer, W. R. Thompson, B. Sen et al., “Cell mechanosensitivity to extremely low–magnitude signals is enabled by a LINCed nucleus,” Stem Cells, vol. 33, no. 6, pp. 2063–2076, 2015.
- D. Havelka, M. Cifra, O. Kucera, J. Pokorny, and J. Vrba, “High–frequency electric field and radiation characteristics of cellular microtubule network,” Journal of Theoretical Biology, vol. 286, no. 1, pp. 31–40, 2011.
- S. Sahu, S. Ghosh, D. Fujita, and A. Bandyopadhyay, “Live visualizations of single isolated tubulin protein self–assembly via tunneling current: effect of electromagnetic pumping during spontaneous growth of microtubule,” Scientific Reports, vol. 4, no. 1, p. 7303, 2014.
- S. Sahu, S. Ghosh, K. Hirata, D. Fujita, and A. Bandyopadhyay, “Multi–level memory–switching properties of a single brain microtubule,” Applied Physics Letters, vol. 102, no. 12, article 123701, 2013.
- I. Cosic, D. Cosic, and K. Lazar, “Is it possible to predict electromagnetic resonances in proteins, DNA and RNA?” EPJ Nonlinear Biomedical Physics, vol. 3, no. 1, p. 5, 2015.
- C. Ventura, F. Bianchi, C. Cavallini, E. Olivi, and R. Tassinari, “The use of physical energy for tissue healing,” European Heart Journal Supplements: Journal of the European Society of Cardiology, vol. 17, pp. A69–A73, 2015.
- F. M. Watt and B. L. Hogan, “Out of Eden: stem cells and their niches,” Science, vol. 287, no. 5457, pp. 1427–1430, 2000.
- Y. Sun, C. S. Chen, and J. Fu, “Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment,” Annual Review of Biophysics, vol. 41, no. 1, pp. 519–542, 2012.
- D. Dado, M. Sagi, S. Levenberg, and A. Zemel, “Mechanical control of stem cell differentiation,” Regenerative Medicine, vol. 7, no. 1, pp. 101–116, 2012.
- D. E. Discher, D. J. Mooney, and P. W. Zandstra, “Growth factors, matrices, and forces combine and control stem cells,” Science, vol. 324, no. 5935, pp. 1673–1677, 2009.
- C. Ventura and L. Tavazzi, “Biophysical signalling from and to the (stem) cells: a novel path to regenerative medicine,” European Journal of Heart Failure, vol. 18, no. 12, pp. 1405–1407, 2016.
- L. Tavazzi and C. Ventura, “Observational medicine: registries and electronic health recording for science and health systems governance,” European Journal of Heart Failure, vol. 18, no. 9, pp. 1093–1095, 2016.
- C. Speed, “A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence,” British Journal of Sports Medicine, vol. 48, no. 21, pp. 1538–1542, 2014.
- C. Ventura, M. Maioli, G. Pintus, G. Gottardi, and F. Bersani, “Elf-pulsed magnetic fields modulate opioid peptide gene expression in myocardial cells,” Cardiovascular Research, vol. 45, no. 4, pp. 1054–1064, 2000.
- R. Nuccitelli, “Endogenous ionic currents and DC electric fields in multicellular animal tissues,” Bioelectromagnetics, vol. 13, pp. 147–157, 1992.
- I. G. Macara and S. Mili, “Polarity and differential inheritance-universal attributes of life?” Cell, vol. 135, no. 5, pp. 801–812, 2008.
- S. W. Lane, D. A. Williams, and F. M. Watt, “Modulating the stem cell niche for tissue regeneration,” Nature Biotechnology, vol. 32, no. 8, pp. 795–803, 2014.
- D. L. Miller, N. B. Smith, M. R. Bailey et al., “Overview of therapeutic ultrasound applications and safety considerations,” Journal of Ultrasound in Medicine, vol. 31, no. 4, pp. 623–634, 2012.
- N. M. Shupak, “Therapeutic uses of pulsed magnetic-field exposure: a review,” URSI Radio Science Bulletin, vol. 307, pp. 9–32, 2003.
- M. S. Markov, “Magnetic field therapy: a review,” Electromagnetic Biology and Medicine, vol. 26, no. 1, pp. 1–23, 2007.
- Y. Liu, W. B. Liu, K. J. Liu et al., “Effect of 50 Hz extremely low-frequency electromagnetic fields on the DNA methylation and DNA methyltransferases in mouse spermatocyte-derived cell line GC-2,” BioMed Research International, vol. 2015, Article ID 237183, 10 pages, 2015.
- L. Leone, S. Fusco, A. Mastrodonato et al., “Epigenetic modulation of adult hippocampal neurogenesis by extremely low-frequency electromagnetic fields,” Molecular Neurobiology, vol. 49, no. 3, pp. 1472–1486, 2014.
- C. Ventura, M. Maioli, Y. Asara et al., “Turning on stem cell cardiogenesis with extremely low frequency magnetic fields,” The FASEB Journal, vol. 19, no. 1, pp. 155–157, 2005.
- M. Maioli, S. Rinaldi, S. Santaniello et al., “Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle differentiation in mouse embryonic stem cells: a new tool for improving tissue regeneration,” Cell Transplantation, vol. 21, no. 6, pp. 1225–1233, 2012.
- M. Maioli, S. Rinaldi, S. Santaniello et al., “Radioelectric asymmetric conveyed fields and human adipose-derived stem cells obtained with a nonenzymatic method and device: a novel approach to multipotency,” Cell Transplantation, vol. 23, no. 12, pp. 1489–1500, 2014.
- M. Maioli, S. Rinaldi, S. Santaniello et al., “Radio electric conveyed fields directly reprogram human dermal–skin fibroblasts toward cardiac–, neuronal–, and skeletal muscle–like lineages,” Cell Transplantation, vol. 22, no. 7, pp. 1227–1235, 2013.
- S. Rinaldi, M. Maioli, G. Pigliaru et al., “Stem cell senescence. Effects of REAC technology on telomerase independent and telomerase–dependent pathways,” Scientific Reports, vol. 4, no. 1, p. 6373, 2014.
- M. Maioli, S. Rinaldi, R. Migheli et al., “Neurological morphofunctional differentiation induced by REAC technology in PC12. A neuro protective model for Parkinson’s disease,” Scientific Reports, vol. 5, no. 1, article 10439, 2015.
- M. Maioli, S. Rinaldi, G. Pigliaru et al., “REAC technology and hyaluron synthase 2, an interesting network to slow down stem cell senescence,” Scientific Reports, vol. 6, no. 1, article 28682, 2016.
- J. M. Kelley, “Extracorporeal shock wave lithotripsy of urinary calculi. Theory, efficacy, and adverse effects,” West Journal of Medicine, vol. 153, pp. 65–69, 1990.
- C. J. Wang, “An overview of shock wave therapy in musculoskeletal disorders,” Chang Gung Medical Journal, vol. 26, no. 4, pp. 220–232, 2003.
- V. Pavone, L. Cannavo, A. Di Stefano, G. Testa, L. Costarella, and G. Sessa, “Low-energy extracorporeal shock-wave therapy in the treatment of chronic insertional Achilles tendinopathy: a case series,” BioMed Research International, vol. 2016, Article ID 7123769, 4 pages, 2016.
- A. Notarnicola and B. Moretti, “The biological effects of extracorporeal shock wave therapy (eswt) on tendon tissue,” Muscles, Ligaments and Tendons Journal, vol. 2, no. 1, pp. 33–37, 2012.
- D. E. Ingber, “Cellular mechanotransduction: putting all the pieces together again,” The FASEB Journal, vol. 20, no. 7, pp. 811–827, 2006.
- Y. J. Chen, Y. R. Kuo, K. D. Yang et al., “Activation of extracellular signal-regulated kinase (ERK) and p38 kinase in shock wave-promoted bone formation of segmental defect in rats,” Bone, vol. 34, no. 3, pp. 466–477, 2004.
- L. Xu, Y. Zhao, M. Wang et al., “Defocused low-energy shock wave activates adipose tissue-derived stem cells in vitro via multiple signaling pathways,” Cytotherapy, vol. 18, no. 12, pp. 1503–1514, 2016.
- L. Rinella, F. Marano, L. Berta et al., “Extracorporeal shock waves modulate myofibroblast differentiation of adipose-derived stem cells,” Wound Repair and Regeneration, vol. 24, no. 2, pp. 275–286, 2016.
- K. Hatanaka, K. Ito, T. Shindo et al., “Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction,” American Journal of Physiology. Cell Physiology, vol. 311, no. 3, pp. C378–C385, 2016.
- X. Zhang, X. Yan, C. Wang, T. Tang, and Y. Chai, “The dose-effect relationship in extracorporeal shock wave therapy: the optimal parameter for extracorporeal shock wave therapy,” The Journal of Surgical Research, vol. 186, no. 1, pp. 484–492, 2014.
- Z. Cai, F. Falkensammer, O. Andrukhov, J. Chen, R. Mittermayr, and X. Rausch-Fan, “Effects of shock waves on expression of IL-6, IL-8, MCP-1, and TNF-α expression by human periodontal ligament fibroblasts: an in vitro study,” Medical Science Monitor, vol. 22, pp. 914–921, 2016.
- P. Romeo, V. Lavanga, D. Pagani, and V. Sansone, “Extracorporeal shock wave therapy in musculoskeletal disorders: a review,” Medical Principles and Practice, vol. 23, no. 1, pp. 7–13, 2014.
- R. Mittermayr, V. Antonic, J. Hartinger et al., “Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy,” Wound Repair and Regeneration, vol. 20, no. 4, pp. 456–465, 2012.
- J. K. Gimzewski, A. Pelling, and C. Ventura, “Nanomechanical characterization of cellular activity,” Tech. Rep., International Patent WO 2008/105919 A2, 2008.
- A. E. Pelling, S. Sehati, E. B. Gralla, J. S. Valentine, and J. K. Gimzewski, “Local nanomechanical motion of the cell wall of Saccharomyces cerevisiae,” Science, vol. 305, no. 5687, pp. 1147–1150, 2004.
Copyright © 2018 Federica Facchin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.